123 related articles for article (PubMed ID: 3000480)
1. Platelet modulation of polymorphonuclear leukocyte shear induced aggregation.
Rhee BG; Hall ER; McIntire LV
Blood; 1986 Jan; 67(1):240-6. PubMed ID: 3000480
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-activated platelets promote leukotriene B4 synthesis in polymorphonuclear leucocytes stimulated by physiological agonists.
Palmantier R; Borgeat P
Br J Pharmacol; 1991 Aug; 103(4):1909-16. PubMed ID: 1655146
[TBL] [Abstract][Full Text] [Related]
3. Characterization of effect of N-formyl-methionyl-leucyl-phenylalanine on leukotriene synthesis in human polymorphonuclear leukocytes.
Salari H; Braquet P; Naccache P; Borgeat P
Inflammation; 1985 Jun; 9(2):127-38. PubMed ID: 2989173
[TBL] [Abstract][Full Text] [Related]
4. U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes.
Dahl ML; Puustinen T; Uotila P
Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):355-65. PubMed ID: 6431565
[TBL] [Abstract][Full Text] [Related]
5. Deficient induction of leukotriene synthesis in human neutrophils by lipoxygenase-deficient platelets.
Kanaji K; Okuma M; Uchino H
Blood; 1986 Apr; 67(4):903-8. PubMed ID: 3006834
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of arachidonic acid in neutrophils from alloxan-diabetic rabbits.
Greco NJ; Milks MM; Panganamala RV
Prostaglandins Leukot Essent Fatty Acids; 1991 Apr; 42(4):201-8. PubMed ID: 1651509
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of the new selective leukotriene synthesis inhibitor BAY X 1005 ((R)-2-[4-(quinolin-2-yl-methoxy)phenyl]-2-cyclopentyl acetic acid) and structurally related compounds.
Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R
Biochem Pharmacol; 1993 Jan; 45(1):101-11. PubMed ID: 8381000
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 5- and 15-lipoxygenase activities in blood and alveolar leukocyte preparations from normal subjects and patients with eosinophilia.
Laviolette M; Picard S; Braquet P; Borgeat P
Prostaglandins Leukot Med; 1986 Aug; 23(2-3):191-9. PubMed ID: 3020586
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene A4, and not leukotriene B4, is the main 5-lipoxygenase metabolite released by bovine leukocytes.
Sala A; Testa T; Folco G
FEBS Lett; 1996 Jun; 388(2-3):94-8. PubMed ID: 8690098
[TBL] [Abstract][Full Text] [Related]
10. The effect of aspirin on the metabolism of exogenous arachidonic acid in human polymorphonuclear leukocytes.
Punnonen K; Uotila P
Prostaglandins Leukot Med; 1984 Aug; 15(2):177-85. PubMed ID: 6436829
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of arachidonic acid by peripheral and elicited rat polymorphonuclear leukocytes. Formation of 18- and 19-oxygenated dihydro metabolites of leukotriene B4.
Powell WS; Gravelle F
J Biol Chem; 1990 Jun; 265(16):9131-9. PubMed ID: 2160957
[TBL] [Abstract][Full Text] [Related]
12. Changes in arachidonic acid metabolism and the aggregation of polymorphonuclear leukocytes in rats with streptozotocin-induced diabetes.
Nakagawa Y; Ishii E
Biochim Biophys Acta; 1996 Mar; 1315(2):145-51. PubMed ID: 8608172
[TBL] [Abstract][Full Text] [Related]
13. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
Williams JD; Lee TH; Lewis RA; Austen F
J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene biosynthesis by polymorphonuclear leukocytes from two patients with chronic granulomatous disease.
Feinmark SJ; Udén AM; Palmblad J; Malmsten C
J Clin Invest; 1983 Nov; 72(5):1839-43. PubMed ID: 6313767
[TBL] [Abstract][Full Text] [Related]
15. Circulating polymorphonuclear leukocytes from patients with gram-negative bacteremia are not primed for enhanced production of leukotriene B4 or 5-hydroxyeicosatetraenoic acid.
Sorrell TC; Sztelma K; May GL
J Infect Dis; 1994 May; 169(5):1151-4. PubMed ID: 8169412
[TBL] [Abstract][Full Text] [Related]
16. Auranofin stimulates LTA hydrolase and inhibits 5-lipoxygenase/LTA synthase activity of isolated human neutrophils.
Betts WH; Hurst NP; Murphy GA; Cleland LG
Biochem Pharmacol; 1990 Apr; 39(7):1233-7. PubMed ID: 2157444
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid metabolism by polymorphonuclear leukocytes in psoriasis.
Maurice PD; Bather PC; Allen BR
Br J Dermatol; 1986 Jan; 114(1):57-64. PubMed ID: 3002416
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.
Beckman JK; Gay JC; Brash AR; Lukens JN; Oates JA
Lipids; 1985 Jun; 20(6):357-60. PubMed ID: 2991693
[TBL] [Abstract][Full Text] [Related]
20. Aggregating and prostanoid-releasing effects of platelet-activating factor and leukotrienes on human polymorphonuclear leukocytes and platelets.
Dahl ML
Int Arch Allergy Appl Immunol; 1985; 76(2):145-50. PubMed ID: 2981776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
